STAAR Surgical (STAA) Competitors $26.66 -0.64 (-2.34%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends STAA vs. EYE, HAE, ICUI, XRAY, NEOG, QDEL, CERS, OSUR, ANIK, and UTMDShould you be buying STAAR Surgical stock or one of its competitors? The main competitors of STAAR Surgical include National Vision (EYE), Haemonetics (HAE), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), Neogen (NEOG), QuidelOrtho (QDEL), Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), and Utah Medical Products (UTMD). These companies are all part of the "medical" sector. STAAR Surgical vs. National Vision Haemonetics ICU Medical DENTSPLY SIRONA Neogen QuidelOrtho Cerus OraSure Technologies Anika Therapeutics Utah Medical Products STAAR Surgical (NASDAQ:STAA) and National Vision (NASDAQ:EYE) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, community ranking, media sentiment and analyst recommendations. Is STAA or EYE more profitable? STAAR Surgical has a net margin of 6.38% compared to National Vision's net margin of -0.81%. STAAR Surgical's return on equity of 6.77% beat National Vision's return on equity.Company Net Margins Return on Equity Return on Assets STAAR Surgical6.38% 6.77% 5.39% National Vision -0.81%3.52%1.39% Does the MarketBeat Community believe in STAA or EYE? STAAR Surgical received 34 more outperform votes than National Vision when rated by MarketBeat users. However, 65.63% of users gave National Vision an outperform vote while only 55.60% of users gave STAAR Surgical an outperform vote. CompanyUnderperformOutperformSTAAR SurgicalOutperform Votes28855.60% Underperform Votes23044.40% National VisionOutperform Votes25465.63% Underperform Votes13334.37% Do insiders & institutionals believe in STAA or EYE? 96.7% of STAAR Surgical shares are held by institutional investors. 1.0% of STAAR Surgical shares are held by insiders. Comparatively, 2.3% of National Vision shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more risk & volatility, STAA or EYE? STAAR Surgical has a beta of 0.61, indicating that its share price is 39% less volatile than the S&P 500. Comparatively, National Vision has a beta of 1.42, indicating that its share price is 42% more volatile than the S&P 500. Does the media refer more to STAA or EYE? In the previous week, STAAR Surgical had 2 more articles in the media than National Vision. MarketBeat recorded 6 mentions for STAAR Surgical and 4 mentions for National Vision. STAAR Surgical's average media sentiment score of 0.99 beat National Vision's score of 0.94 indicating that STAAR Surgical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive National Vision 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer STAA or EYE? STAAR Surgical currently has a consensus price target of $43.33, indicating a potential upside of 62.54%. National Vision has a consensus price target of $14.00, indicating a potential upside of 26.93%. Given STAAR Surgical's stronger consensus rating and higher probable upside, equities research analysts clearly believe STAAR Surgical is more favorable than National Vision.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score STAAR Surgical 1 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.38National Vision 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has better earnings and valuation, STAA or EYE? STAAR Surgical has higher earnings, but lower revenue than National Vision. National Vision is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSTAAR Surgical$341.22M3.85$21.35M$0.4460.59National Vision$2.13B0.41-$65.90M-$0.20-55.15 SummarySTAAR Surgical beats National Vision on 14 of the 18 factors compared between the two stocks. Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Get STAAR Surgical News Delivered to You Automatically Sign up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STAA vs. The Competition Export to ExcelMetricSTAAR SurgicalOphthalmic goods IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.31B$11.34B$5.06B$8.67BDividend YieldN/A1.63%5.06%4.06%P/E Ratio60.5935.3798.9217.12Price / Sales3.854.741,205.7371.29Price / Cash38.8617.9840.6936.36Price / Book3.073.096.325.87Net Income$21.35M$224.33M$119.47M$225.66M7 Day Performance-9.90%-3.37%-5.11%-1.34%1 Month Performance-16.84%-1.48%-3.21%1.00%1 Year Performance-24.39%15.28%32.41%25.27% STAAR Surgical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STAASTAAR Surgical4.8603 of 5 stars$26.66-2.3%$43.33+62.5%-24.4%$1.31B$341.22M60.591,115Short Interest ↓EYENational Vision3.7112 of 5 stars$11.03+0.7%$14.00+26.9%-42.3%$868.61M$2.13B-55.1513,998Short Interest ↓HAEHaemonetics4.784 of 5 stars$89.22-1.7%$107.88+20.9%+0.0%$4.48B$1.36B37.023,657Analyst ForecastNews CoverageICUIICU Medical4.1571 of 5 stars$167.86-2.4%$173.00+3.1%+92.7%$4.11B$2.34B-36.7314,000Analyst DowngradeShort Interest ↓News CoverageXRAYDENTSPLY SIRONA4.9012 of 5 stars$18.28+2.3%$29.50+61.4%-38.2%$3.63B$3.90B-8.8315,000NEOGNeogen2.22 of 5 stars$14.60-0.3%$17.50+19.9%-8.5%$3.16B$912.20M-132.732,640QDELQuidelOrtho4.437 of 5 stars$36.18-7.1%$58.83+62.6%-44.8%$2.43B$2.82B-1.307,100Options VolumeCERSCerus2.8499 of 5 stars$1.72-4.4%$3.63+110.8%-0.6%$319.43M$176.23M-15.64625Short Interest ↑OSUROraSure Technologies4.6184 of 5 stars$3.85-3.5%$6.67+73.2%-44.2%$287.17M$405.47M25.67638ANIKAnika Therapeutics3.8926 of 5 stars$17.25+1.5%$24.50+42.0%-17.6%$252.64M$164.17M-2.59357High Trading VolumeUTMDUtah Medical Products3.3408 of 5 stars$66.05-0.7%N/A-22.2%$225.61M$50.22M15.47180Positive News Related Companies and Tools Related Companies National Vision Competitors Haemonetics Competitors ICU Medical Competitors DENTSPLY SIRONA Competitors Neogen Competitors QuidelOrtho Competitors Cerus Competitors OraSure Technologies Competitors Anika Therapeutics Competitors Utah Medical Products Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:STAA) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STAAR Surgical Please log in to your account or sign up in order to add this asset to your watchlist. Share STAAR Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.